Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
In: Breast Cancer Research and Treatment, Jg. 175 (2019-06-01), Heft 2, S. 389-399
Online
academicJournal
Zugriff:
Titel: |
Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
|
---|---|
Autor/in / Beteiligte Person: | Wuerstlein, R. ; Kates, R. ; Gluz, O. ; Grischke, E. M. ; Schem, C. ; Thill, M. ; Hasmueller, S. ; Köhler, A. ; Otremba, B. ; Griesinger, F. ; Schindlbeck, C. ; Trojan, A. ; Otto, F. ; Knauer, M. ; Pusch, R. ; Harbeck, N. ; WSG-PRIMe investigators in Germany, Austria, Switzerland |
Link: | |
Zeitschrift: | Breast Cancer Research and Treatment, Jg. 175 (2019-06-01), Heft 2, S. 389-399 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
ISSN: | 0167-6806 (print) ; 1573-7217 (print) |
DOI: | 10.1007/s10549-018-05075-x |
Sonstiges: |
|